Abstract
Seminal studies by Richardson [1] and Thornton [2] defined the constraints imposed by protein structure on disulfide formation and flagged forbidden regions of primary or secondary structure seemingly incapable of forming disulfide bonds between resident cysteine pairs. With respect to secondary structure, disulfide bonds were not found between cysteine pairs: A. on adjacent β-stands [1]; B. in a single helix or strand [2]; C. on non-adjacent strands of the same β-sheet [2]. In primary structure, disulfide bonds were not found between cysteine pairs: D. adjacent in the sequence [2]. In the intervening years it has become apparent that all these forbidden regions are indeed occupied by disulfide-bonded cysteines, albeit rather strained ones. It has been observed that sources of strain in a protein structure, such as residues in forbidden regions of the Ramachandran plot and cis-peptide bonds, are found in functionally important regions of the protein and warrant further investigation [3-5]. Like the Ramachandran plot, the earlier studies by Richardson [1] and Thornton [2] have identified a fundamental truth in protein stereochemistry: “forbidden” disulfides adopt strained conformations, but there is likely a functional reason for this. Emerging evidence supports a role for forbidden disulfides in redoxregulation of proteins.
Keywords: Redox-active disulfide, redox signaling, cross-strand disulfide, cytokine receptor, major histocompatibility complex
Current Protein & Peptide Science
Title: “Forbidden” Disulfides: Their Role as Redox Switches
Volume: 8 Issue: 5
Author(s): M. A. Wouters, R. A. George and N. L. Haworth
Affiliation:
Keywords: Redox-active disulfide, redox signaling, cross-strand disulfide, cytokine receptor, major histocompatibility complex
Abstract: Seminal studies by Richardson [1] and Thornton [2] defined the constraints imposed by protein structure on disulfide formation and flagged forbidden regions of primary or secondary structure seemingly incapable of forming disulfide bonds between resident cysteine pairs. With respect to secondary structure, disulfide bonds were not found between cysteine pairs: A. on adjacent β-stands [1]; B. in a single helix or strand [2]; C. on non-adjacent strands of the same β-sheet [2]. In primary structure, disulfide bonds were not found between cysteine pairs: D. adjacent in the sequence [2]. In the intervening years it has become apparent that all these forbidden regions are indeed occupied by disulfide-bonded cysteines, albeit rather strained ones. It has been observed that sources of strain in a protein structure, such as residues in forbidden regions of the Ramachandran plot and cis-peptide bonds, are found in functionally important regions of the protein and warrant further investigation [3-5]. Like the Ramachandran plot, the earlier studies by Richardson [1] and Thornton [2] have identified a fundamental truth in protein stereochemistry: “forbidden” disulfides adopt strained conformations, but there is likely a functional reason for this. Emerging evidence supports a role for forbidden disulfides in redoxregulation of proteins.
Export Options
About this article
Cite this article as:
Wouters A. M., George A. R. and Haworth L. N., “Forbidden” Disulfides: Their Role as Redox Switches, Current Protein & Peptide Science 2007; 8 (5) . https://dx.doi.org/10.2174/138920307782411464
DOI https://dx.doi.org/10.2174/138920307782411464 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Review of Procedures Used for the Extraction of Anti-Cancer Compounds from Tropical Plants
Anti-Cancer Agents in Medicinal Chemistry Hydroxychloroquine (HCQ) and its Synthetic Precursors: A Review
Mini-Reviews in Organic Chemistry Agents Targeting Prostate Cancer Bone Metastasis
Anti-Cancer Agents in Medicinal Chemistry Anti-Cancer Approach with NK4: Bivalent Action and Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Diagnosis and Treatment of Paraneoplastic Neurological Syndromes
Current Clinical Pharmacology Viral Disorder or Disordered Viruses: Do Viral Proteins Possess Unique Features?
Protein & Peptide Letters The Co-regulatory Role of 5-Lipoxygenase and Cyclooxygenase-2 in the Carcinogenesis and their Promotion by Cigarette Smoking in Colons
Current Medicinal Chemistry Inhibitory Effect of Fruit Juices on the Doxorubicin Metabolizing Activity of Carbonyl Reductase 1
Drug Metabolism Letters Cancer Cachexia: One Step Ahead
Reviews on Recent Clinical Trials Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances
Current Pharmaceutical Biotechnology Design, Synthesis and Antiplasmodial Evaluation of Sulfoximine-triazole Hybrids as Potential Antimalarial Prototypes
Medicinal Chemistry The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy
Current Radiopharmaceuticals TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges
Reviews on Recent Clinical Trials Graphical Abstracts
Current Nanoscience Lung Cancer of Occupational Origin
Current Respiratory Medicine Reviews Hybolites Revisited
Recent Patents on Anti-Infective Drug Discovery Nanotechnology for Delivery of Drugs and Biomedical Applications
Current Clinical Pharmacology Perspective of Molecular Hydrogen in the Treatment of Sepsis
Current Pharmaceutical Design The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer
Current Drug Targets Gender Differences in Ischemic Heart Disease
Recent Patents on Cardiovascular Drug Discovery